<- Go Home
Knight Therapeutics Inc.
Knight Therapeutics Inc. operates as a specialty pharmaceutical company that focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing pharmaceutical products in Canada and Latin America. The company was founded in 2014 and is based in Montreal, Canada. It operates in additional locations in Latin America, such as Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Mexico, Paraguay, Peru, and Uruguay.
Market Cap
CAD 584.3M
Volume
78.5K
Cash and Equivalents
CAD 80.1M
EBITDA
CAD 56.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
CAD 174.4M
Profit Margin
46.97%
52 Week High
CAD 6.45
52 Week Low
CAD 5.08
Dividend
N/A
Price / Book Value
0.74
Price / Earnings
146.50
Price / Tangible Book Value
1.38
Enterprise Value
CAD 461.0M
Enterprise Value / EBITDA
7.74
Operating Income
CAD 7.4M
Return on Equity
0.56%
Return on Assets
0.48
Cash and Short Term Investments
CAD 172.8M
Debt
CAD 49.5M
Equity
CAD 795.1M
Revenue
CAD 371.3M
Unlevered FCF
-CAD 3.9M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium